Mock James M

Mock James M serves as the Chief Financial Officer of Moderna, Inc., a prominent player in the healthcare sector. His role involves overseeing financial strategies and operations within the company, which is known for its innovative mRNA technology. Between December 6, 2024, and July 6, 2026, Mock has made 53 public disclosures related to his insider trading activities, all concerning Moderna, Inc. (MRNA). The disclosures reveal a range of reported amounts from $51.0K to $17.6K, with the most significant transaction being a grant/exercise valued at over $2.0 million on March 3, 2026.